HBC business: slight sales growth, lower operating income
First written in FY2016-Q2. 15 of 35 entries say "Worsened", first in FY2016-Q3. Latest entry: FY2026-H1.
Astena Holdings moved to the "Worse" side of this theme in 2016, 8 years before the typical company in this theme (2024).
The whole theme swung hardest in 2026: 19 of 79 companies on the "Worse" side.
33 other companies' latest entry also says "Other".
- FY2026-H1Revenue Growth and Profit DeclineAnnual report
「Accordingly, total segment net sales were ¥11,359 million, up 41.7% year on year, and operating profit was ¥360 million, down 33.9%.」
Sales increased substantially due to the consolidation of 池田物産グループ and strong sales of Korean cosmetics, while profit declined due to costs for strengthening the sales organization, a reactionary decline in sales of research reagents and other products, and temporary PMI-related costs for 池田物産グループ. - 2026-04-13AdvancedEarnings
「As a result, total sales for this business were ¥5.504 billion, up 49.8% year on year, and operating income was ¥265 million, up 27.5%.」
The HBC and food business continued to report increases in sales and operating income, with the extent of growth in both figures specified. - FY2025-H1AdvancedAnnual report
「Accordingly, total segment net sales were ¥8,017 million, up 19.6% year on year, and operating profit was ¥544 million, up 174.1%.」
The HBC and Food business posted a 19.6% increase in sales and a 174.1% increase in operating profit, with growth in both sales and profit accelerating. - FY2024MitigatedAnnual report
「Accordingly, total segment net sales were ¥15,162 million, up 7.8% year on year, and operating profit was ¥742 million, up 128.4%.」
The HBC and Food business posted higher sales and operating profit, with operating profit up 128.4% year on year. The withdrawal from the unprofitable wholesale business for over-the-counter drugs and other products was also disclosed. - FY2024-Q2MitigatedAnnual report
「Accordingly, total segment net sales were ¥6,702 million, down 23.9% year on year, and operating profit was ¥258 million, up 236.4% year on year.」
Sales declined following the withdrawal from the wholesale business for over-the-counter drugs and other products, while operating profit improved substantially due to the withdrawal from unprofitable businesses and strong cosmetics sales. - FY2024-Q1MitigatedAnnual report
「Accordingly, total segment net sales were ¥2,980 million, down 29.3% year on year, and operating profit was ¥93 million, compared with an operating loss of ¥41 million in the same period of the previous year.」
Sales declined following the withdrawal from the wholesale business for over-the-counter drugs and other products, while the business turned an operating loss into operating profit following its withdrawal from unprofitable businesses. - FY2023-Q3MitigatedAnnual report
「Accordingly, total segment net sales were ¥12,651 million, up 21.1% year on year, and operating profit was ¥191 million, compared with an operating loss of ¥91 million in the same period of the previous year.」
The HBC and Food business posted a 21.1% year-on-year increase in sales and turned an operating loss into operating profit of ¥191 million. - FY2023-Q2MitigatedAnnual report
「Accordingly, total segment net sales were ¥8,812 million, up 22.4% year on year, and operating profit was ¥78 million, compared with an operating loss of ¥65 million in the same period of the previous year.」
The HBC and Food business posted higher sales and turned an operating loss in the same period of the previous year into operating profit. - FY2023-Q1MitigatedAnnual report
「Accordingly, total segment net sales were ¥4,218 million, up 18.8% year on year, and the operating loss was ¥40 million, compared with an operating loss of ¥95 million in the same period of the previous year.」
The HBC and Food business posted higher sales, and the operating loss narrowed from the same period of the previous year. - FY2022MitigatedAnnual report
「Accordingly, total segment net sales were ¥13,970 million, compared with ¥28,238 million in the same period of the previous year, and operating profit was ¥141 million, compared with an operating loss of ¥343 million in the same period of the previous year.」
Although this included a decline in reported sales due to the application of the revenue recognition accounting standard, the HBC and Food business turned an operating loss into operating profit. - FY2022-Q3MitigatedAnnual report
「Accordingly, total segment net sales were ¥10,444 million, compared with ¥20,849 million in the same period of the previous year, and the operating loss was ¥91 million, compared with an operating loss of ¥442 million in the same period of the previous year.」
Although this included a decline in sales due to the application of the revenue recognition accounting standard, the operating loss of the HBC and Food business narrowed from ¥442 million in the same period of the previous year to ¥91 million. - FY2022-Q2MitigatedAnnual report
「Accordingly, total segment net sales were ¥7,201 million, compared with ¥14,001 million in the same period of the previous year, and the operating loss was ¥65 million, compared with an operating loss of ¥349 million in the same period of the previous year.」
Although this included a decline in sales due to the application of the revenue recognition accounting standard, the operating loss of the HBC and Food business narrowed substantially from ¥349 million in the same period of the previous year to ¥65.8 million. - FY2022-Q1MitigatedAnnual report
「Accordingly, total segment net sales were ¥3,549 million, compared with ¥6,588 million in the same period of the previous year, and the operating loss was ¥95 million, compared with ¥235 million in the same period of the previous year.」
Although this included a decline in sales due to the application of the revenue recognition accounting standard, the operating loss of the HBC and Food business narrowed substantially from the same period of the previous year. - FY2021-Q3WorsenedAnnual report
「Accordingly, total segment net sales were ¥20,849 million, up 7.0% year on year, and the operating loss was ¥442 million, compared with an operating loss of ¥401 million in the same period of the previous year.」
The HBC and Food business posted higher sales, while the operating loss widened from ¥401 million in the same period of the previous year to ¥442 million. - FY2021-Q2WorsenedAnnual report
「Accordingly, total segment net sales were ¥14,001 million, up 6.3% year on year, and the operating loss was ¥349 million, compared with an operating loss of ¥179 million in the same period of the previous year.」
The HBC and Food business posted higher sales, while the operating loss widened from ¥179 million in the same period of the previous year to ¥349 million. - FY2021-Q1WorsenedAnnual report
「Accordingly, total segment net sales were ¥6,588 million, down 4.1% year on year, and the operating loss was ¥235 million, compared with an operating loss of ¥118 million in the same period of the previous year.」
The HBC and Food business posted lower sales, and the operating loss widened from ¥118 million in the same period of the previous year to ¥235 million. - FY2020WorsenedAnnual report
「Accordingly, total segment net sales were ¥25,811 million, down 9.0% year on year, and the operating loss was ¥490 million, compared with an operating loss of ¥44 million in the same period of the previous year.」
The HBC and Food business posted lower sales, and the operating loss widened from ¥44 million in the previous year to ¥490 million. - FY2020-Q3WorsenedAnnual report
「Accordingly, total segment net sales were ¥19,488 million, down 9.0% year on year, and the operating loss was ¥401 million, compared with an operating loss of ¥41 million in the same period of the previous year.」
The HBC and Food business posted lower sales, and the operating loss widened from ¥41 million in the same period of the previous year to ¥401 million. - FY2020-Q2WorsenedAnnual report
「Accordingly, total segment net sales were ¥13,173 million, down 9.3% year on year, and the operating loss was ¥179 million, compared with operating profit of ¥25 million in the same period of the previous year.」
The HBC and Food business posted lower sales and turned operating profit in the same period of the previous year into an operating loss. - FY2020-Q1WorsenedAnnual report
「Accordingly, total segment net sales were ¥6,869 million, down 3.5% year on year, and the operating loss was ¥118 million, compared with operating profit of ¥18 million in the same period of the previous year.」
On a post-integration basis, the HBC and Food business posted lower sales and turned operating profit in the same period of the previous year into an operating loss. - FY2019WorsenedAnnual report
「Accordingly, total segment net sales were ¥24,138 million, down 1.9% year on year, and the operating loss was ¥0 million, compared with operating profit of ¥234 million in the same period of the previous year.」
The HBC business posted lower sales and turned the previous year's operating profit into an operating loss. - FY2019-Q3WorsenedAnnual report
「Accordingly, total segment net sales were ¥18,229 million, down 0.6% year on year, and the operating loss was ¥20 million, compared with operating profit of ¥128 million in the same period of the previous year.」
The HBC business posted lower sales and turned operating profit in the same period of the previous year into an operating loss. - FY2019-Q2WorsenedAnnual report
「Accordingly, total segment net sales were ¥12,350 million, up 1.6% year on year, and operating profit was ¥35 million, down 57.3%.」
The HBC business posted higher sales, while operating profit fell 57.3% year on year due to higher costs, including surging logistics expenses. - FY2019-Q1MitigatedAnnual report
「Accordingly, total segment net sales were ¥6,036 million, up 3.0% year on year, and operating profit was ¥23 million, compared with an operating loss of ¥58 million in the same period of the previous year.」
The HBC business posted higher sales and turned an operating loss in the same period of the previous year into operating profit. - FY2018MitigatedAnnual report
「Accordingly, total segment net sales were ¥24,611 million, up 4.3% year on year, and operating profit was ¥234 million, up 124.6%.」
The HBC business posted higher sales and operating profit for the full year, with operating profit improving 124.6% year on year to ¥234 million. - FY2018-Q3MitigatedAnnual report
「Accordingly, total business sales were ¥18,338 million, up 6.1% year on year, and operating income was ¥128 million, compared with an operating loss of ¥6 million in the year-earlier period.」
The HBC business posted higher sales and moved from an operating loss to operating income. - FY2018-Q2MitigatedAnnual report
「Accordingly, total business sales were ¥12,154 million, up 6.5% year on year, and operating income was ¥82 million, up 483.2%.」
The HBC business posted higher sales, and operating income also improved substantially, rising 483.2% year on year. - FY2018-Q1WorsenedAnnual report
「Accordingly, total business sales were ¥5,862 million, up 8.2% year on year, and the business posted an operating loss of ¥58 million, compared with operating income of ¥31 million in the year-earlier period.」
The HBC business posted higher sales but moved from operating income to an operating loss. - FY2017MitigatedAnnual report
「Accordingly, total business sales were ¥23,591 million, up 5.9% year on year, and operating income was ¥104 million, up 40.2%.」
The HBC business posted higher sales and operating income for the full year, with operating income improving from ¥74.38 million in the previous year to ¥104 million. - FY2017-Q3WorsenedAnnual report
「Accordingly, total business sales were ¥17,290 million, up 5.1% year on year, and the business posted an operating loss of ¥6 million, compared with operating income of ¥23 million in the year-earlier period.」
The HBC business posted higher sales but moved from operating income in the year-earlier period to an operating loss. - FY2017-Q2WorsenedAnnual report
「Accordingly, total business sales were ¥11,416 million, up 5.0% year on year, and operating income was ¥14 million, down 33.5%.」
HBC business sales continued to increase, while operating income fell 33.5% year on year, widening the decline in profit. - FY2017-Q1Returned to revenue growth, but profit decline continuedAnnual report
「Accordingly, total business sales were ¥5,418 million, up 3.3% year on year, and operating income was ¥31 million, down 15.1%.」
HBC business sales turned to growth year on year, while operating income declined. - FY2016WorsenedAnnual report
「Total business sales were ¥22,281 million, down 1.1% from the previous consolidated fiscal year, and operating income was ¥74 million, down 59.7%.」
The HBC business posted lower sales for the full year, while operating income also fell 59.7% year on year. - FY2016-Q3WorsenedAnnual report
「Accordingly, total business sales were ¥16,453 million, down 2.1%, and operating income was ¥23 million, down 80.1%.」
The HBC business posted lower sales, and operating income fell 80.1% year on year. - FY2016-Q2First statedAnnual report
「Accordingly, total business sales were ¥10,870 million, up 0.5%, and operating income was ¥21 million, down 21.1%.」
HBC business sales remained around the year-earlier level, while operating income declined.